<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;ff=20241212195718
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;ff=20241212195718" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Fri, 13 Dec 2024 00:57:19 +0000</lastbuilddate>
<pubDate>Thu, 12 Dec 2024 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Rheumatic Valve Surgery in Sudan: Results in 7,449 Patients at the Salam Centre for Cardiac Surgery</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39665704/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Dec 3:S0735-1097(24)10032-0. doi: 10.1016/j.jacc.2024.09.1232. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39665704/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39665704</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.09.1232>10.1016/j.jacc.2024.09.1232</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39665704</guid>
<pubDate>Thu, 12 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Gina Portella</dc:creator>
<dc:creator>Liliane Chatenoud</dc:creator>
<dc:creator>Sofia Gatti</dc:creator>
<dc:creator>Alessandro C Salvati</dc:creator>
<dc:creator>Lino Asta</dc:creator>
<dc:creator>Salvatore Lentini</dc:creator>
<dc:creator>Juha Puntila</dc:creator>
<dc:creator>Franco Masini</dc:creator>
<dc:creator>Sofia Redaelli</dc:creator>
<dc:creator>Alessandro Mocini</dc:creator>
<dc:creator>Suha Abdelwahab Abdallah</dc:creator>
<dc:creator>Sohayda Hussein Abdalla Abdalla</dc:creator>
<dc:creator>Nicoletta Erba</dc:creator>
<dc:creator>Elena Giovanella</dc:creator>
<dc:creator>Dimiana Raafat Shafig Saber</dc:creator>
<dc:creator>Daniela Rocchi</dc:creator>
<dc:creator>Manahel Badr Saad</dc:creator>
<dc:creator>Lorenzo Valgoi</dc:creator>
<dc:creator>Paolo Malerba</dc:creator>
<dc:creator>Luca Rolla</dc:creator>
<dc:creator>Antonio Pesenti</dc:creator>
<dc:creator>Roberto Latini</dc:creator>
<dc:creator>Pietro Parrino</dc:creator>
<dc:creator>Rossella Miccio</dc:creator>
<dc:creator>Martin Langer</dc:creator>
<dc:creator>Salam Centre Working Group</dc:creator>
<dc:date>2024-12-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Rheumatic Valve Surgery in Sudan: Results in 7,449 Patients at the Salam Centre for Cardiac Surgery</dc:title>
<dc:identifier>pmid:39665704</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.09.1232</dc:identifier>
</item>
<item>
<title>2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis: A Report of the American College of Cardiology Solution Set Oversight Committee</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39665703/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Dec 4:S0735-1097(24)10040-X. doi: 10.1016/j.jacc.2024.10.080. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39665703/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39665703</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.10.080>10.1016/j.jacc.2024.10.080</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39665703</guid>
<pubDate>Thu, 12 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Writing Committee</dc:creator>
<dc:creator>Mark H Drazner</dc:creator>
<dc:creator>Biykem Bozkurt</dc:creator>
<dc:creator>Leslie T Cooper</dc:creator>
<dc:creator>Niti R Aggarwal</dc:creator>
<dc:creator>Cristina Basso</dc:creator>
<dc:creator>Nicole M Bhave</dc:creator>
<dc:creator>Alida L P Caforio</dc:creator>
<dc:creator>Vanessa M Ferreira</dc:creator>
<dc:creator>Bettina Heidecker</dc:creator>
<dc:creator>Amy R Kontorovich</dc:creator>
<dc:creator>Pilar Martín</dc:creator>
<dc:creator>Gregory A Roth</dc:creator>
<dc:creator>Jennifer E Van Eyk</dc:creator>
<dc:date>2024-12-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis: A Report of the American College of Cardiology Solution Set Oversight Committee</dc:title>
<dc:identifier>pmid:39665703</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.10.080</dc:identifier>
</item>
<item>
<title>Intraindividual Variability in Serial Lipoprotein(a) Concentrations Among Placebo-Treated Patients in the OCEAN(a)-DOSE Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39665702/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Dec 4:S0735-1097(24)10043-5. doi: 10.1016/j.jacc.2024.10.081. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39665702/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39665702</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.10.081>10.1016/j.jacc.2024.10.081</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39665702</guid>
<pubDate>Thu, 12 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Prakriti Gaba</dc:creator>
<dc:creator>Robert S Rosenson</dc:creator>
<dc:creator>J Antonio G López</dc:creator>
<dc:creator>Gerald F Watts</dc:creator>
<dc:creator>Thorsten M Leucker</dc:creator>
<dc:creator>Julia F Kuder</dc:creator>
<dc:creator>KyungAh Im</dc:creator>
<dc:creator>Helina Kassahun</dc:creator>
<dc:creator>Huei Wang</dc:creator>
<dc:creator>You Wu</dc:creator>
<dc:creator>Jingying Wang</dc:creator>
<dc:creator>E Magnus Ohman</dc:creator>
<dc:creator>Marc S Sabatine</dc:creator>
<dc:creator>Michelle L O'Donoghue</dc:creator>
<dc:date>2024-12-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Intraindividual Variability in Serial Lipoprotein(a) Concentrations Among Placebo-Treated Patients in the OCEAN(a)-DOSE Trial</dc:title>
<dc:identifier>pmid:39665702</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.10.081</dc:identifier>
</item>
<item>
<title>Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: Prespecified Analysis of FINEARTS-HF</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39665701/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: In patients with HF with mildly reduced/preserved ejection fraction, the beneficial effects of finerenone on clinical events and symptoms were consistent, irrespective of BMI at baseline, possibly with a greater effect on the primary outcome in patients with higher BMI. (FINEARTS-HF [FINerenone trial to investigate Efficacy and sAfety superioR to placebo in paTientS with Heart Failure]; NCT04435626).</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Dec 4:S0735-1097(24)10423-8. doi: 10.1016/j.jacc.2024.10.111. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Obesity is associated with excessive adipocyte-derived aldosterone secretion, independent of the classical renin-angiotensin-aldosterone cascade, and mineralocorticoid receptor antagonists may be more effective in patients with heart failure (HF) and obesity.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: This study sought to examine the effects of the nonsteroidal mineralocorticoid receptor antagonist finerenone compared with placebo, according to body mass index (BMI) in FINEARTS-HF (FINerenone trial to investigate Efficacy and sAfety superioR to placebo in paTientS with Heart Failure).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A total of 6,001 patients with HF with NYHA functional class II, III, and IV, a left ventricular ejection fraction of ≥40%, evidence of structural heart disease, and elevated natriuretic peptide levels were randomized to finerenone or placebo. BMI (kg/m<sup>2</sup>) was examined using World Health Organization categories, namely, underweight/normal weight (&lt;25.0 kg/m<sup>2</sup>; n = 1,306); overweight (25.0-29.9 kg/m<sup>2</sup>; n = 1,990); obesity class I (30.0-34.9 kg/m<sup>2</sup>; n = 1,546); obesity class II (35.0-39.9 kg/m<sup>2</sup>; n = 751); and obesity class III (≥40 kg/m<sup>2</sup>; n = 395). The primary outcome was cardiovascular death and total worsening HF events.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Data on baseline BMI were available for 5,988 patients (median: 29.2 kg/m<sup>2</sup>; Q1-Q3: 25.5-33.6 kg/m<sup>2</sup>). Compared with patients who were underweight/normal weight, those with obesity class II or III had a higher risk of the primary outcome (underweight/normal weight, reference; overweight, unadjusted rate ratio: 0.96 [95% CI: 0.81-1.15]; obesity class I: 1.04 [95% CI: 0.86-1.26]; obesity class II-III: 1.26 [95% CI: 1.03-1.54]). The effect of finerenone on the primary outcome did not vary by baseline BMI (underweight/normal weight, rate ratio: 0.80 [95% CI: 0.62-1.04]; overweight: 0.91 [95% CI: 0.72-1.15]; obesity class I: 0.92 [95% CI: 0.72-1.19]; obesity class II-III: 0.67 [95% CI: 0.50-0.89]; P<sub>interaction</sub> = 0.32). However, when BMI was examined as a continuous variable, the beneficial effect of finerenone seemed to be greater in those with a higher BMI (P<sub>interaction</sub> = 0.005). A similar pattern was observed for total worsening HF events. Consistent effects across baseline BMI were observed for cardiovascular and all-cause death and improvement in the Kansas City Cardiomyopathy Questionnaire scores.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In patients with HF with mildly reduced/preserved ejection fraction, the beneficial effects of finerenone on clinical events and symptoms were consistent, irrespective of BMI at baseline, possibly with a greater effect on the primary outcome in patients with higher BMI. (FINEARTS-HF [FINerenone trial to investigate Efficacy and sAfety superioR to placebo in paTientS with Heart Failure]; NCT04435626).</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39665701/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39665701</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.10.111>10.1016/j.jacc.2024.10.111</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39665701</guid>
<pubDate>Thu, 12 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Jawad H Butt</dc:creator>
<dc:creator>Alasdair D Henderson</dc:creator>
<dc:creator>Pardeep S Jhund</dc:creator>
<dc:creator>Brian L Claggett</dc:creator>
<dc:creator>Akshay S Desai</dc:creator>
<dc:creator>James Lay-Flurrie</dc:creator>
<dc:creator>Prabhakar Viswanathan</dc:creator>
<dc:creator>Andrea Lage</dc:creator>
<dc:creator>Markus F Scheerer</dc:creator>
<dc:creator>Carolyn S P Lam</dc:creator>
<dc:creator>Michele Senni</dc:creator>
<dc:creator>Sanjiv J Shah</dc:creator>
<dc:creator>Adriaan A Voors</dc:creator>
<dc:creator>Johann Bauersachs</dc:creator>
<dc:creator>Cândida Fonseca</dc:creator>
<dc:creator>Mikhail N Kosiborod</dc:creator>
<dc:creator>Gerard C M Linssen</dc:creator>
<dc:creator>Mark C Petrie</dc:creator>
<dc:creator>Morten Schou</dc:creator>
<dc:creator>Subodh Verma</dc:creator>
<dc:creator>Faiez Zannad</dc:creator>
<dc:creator>Bertram Pitt</dc:creator>
<dc:creator>Muthiah Vaduganathan</dc:creator>
<dc:creator>Scott D Solomon</dc:creator>
<dc:creator>John J V McMurray</dc:creator>
<dc:date>2024-12-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: Prespecified Analysis of FINEARTS-HF</dc:title>
<dc:identifier>pmid:39665701</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.10.111</dc:identifier>
</item>
<item>
<title>Real-World Efficacy and Safety of Inclisiran: A Single-Country, Multicenter, Observational Study (CHOLINET Registry)</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39665700/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Dec 4:S0735-1097(24)10318-X. doi: 10.1016/j.jacc.2024.10.106. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39665700/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39665700</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.10.106>10.1016/j.jacc.2024.10.106</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39665700</guid>
<pubDate>Thu, 12 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Paola Gargiulo</dc:creator>
<dc:creator>Federica Marzano</dc:creator>
<dc:creator>Mario Crisci</dc:creator>
<dc:creator>Rossella Marcucci</dc:creator>
<dc:creator>Dario Bruzzese</dc:creator>
<dc:creator>Alessandro Maloberti</dc:creator>
<dc:creator>Filippo Maria Sarullo</dc:creator>
<dc:creator>Gennaro Galasso</dc:creator>
<dc:creator>Ciro Indolfi</dc:creator>
<dc:creator>Giuseppe Musumeci</dc:creator>
<dc:creator>Antonella Corleto</dc:creator>
<dc:creator>Paolo Calabrò</dc:creator>
<dc:creator>Stefano Carugo</dc:creator>
<dc:creator>Gavino Casu</dc:creator>
<dc:creator>Amedeo Picciolo</dc:creator>
<dc:creator>Marco Matteo Ciccone</dc:creator>
<dc:creator>Claudio Bilato</dc:creator>
<dc:creator>Alberto Polimeni</dc:creator>
<dc:creator>Francesco Giallauria</dc:creator>
<dc:creator>Angelo Catalano</dc:creator>
<dc:creator>Leonardo De Luca</dc:creator>
<dc:creator>Giampaolo Niccoli</dc:creator>
<dc:creator>Elio Venturini</dc:creator>
<dc:creator>Marco Pepe</dc:creator>
<dc:creator>Roberta Montisci</dc:creator>
<dc:creator>Natale Daniele Brunetti</dc:creator>
<dc:creator>Giuseppe Patti</dc:creator>
<dc:creator>Italo Porto</dc:creator>
<dc:creator>Alberto Margonato</dc:creator>
<dc:creator>Marina Floresta</dc:creator>
<dc:creator>Saverio Muscoli</dc:creator>
<dc:creator>Matteo Cameli</dc:creator>
<dc:creator>Giuseppe Andò</dc:creator>
<dc:creator>Emilio Di Lorenzo</dc:creator>
<dc:creator>Martina Berteotti</dc:creator>
<dc:creator>Cristina Giannattasio</dc:creator>
<dc:creator>Silvia Sarullo</dc:creator>
<dc:creator>Ciro Formisano</dc:creator>
<dc:creator>Assunta Di Costanzo</dc:creator>
<dc:creator>Fabrizio Delnevo</dc:creator>
<dc:creator>Ferdinando Varbella</dc:creator>
<dc:creator>Arturo Cesaro</dc:creator>
<dc:creator>Monica Franzese</dc:creator>
<dc:creator>Costantino Mancusi</dc:creator>
<dc:creator>Sara Fontanarosa</dc:creator>
<dc:creator>Mariafrancesca Di Santo</dc:creator>
<dc:creator>Ciro Cotticelli</dc:creator>
<dc:creator>Fabrizio Perrone Filardi</dc:creator>
<dc:creator>Stefania Paolillo</dc:creator>
<dc:creator>Giovanni Esposito</dc:creator>
<dc:creator>Alberto Corsini</dc:creator>
<dc:creator>Pasquale Perrone Filardi</dc:creator>
<dc:creator>CHOLINET Investigators</dc:creator>
<dc:date>2024-12-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Real-World Efficacy and Safety of Inclisiran: A Single-Country, Multicenter, Observational Study (CHOLINET Registry)</dc:title>
<dc:identifier>pmid:39665700</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.10.106</dc:identifier>
</item>
<item>
<title>Transcatheter Aortic Valve Replacement in Heart Failure, Reduced Ejection Fraction, and Moderate Aortic Stenosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39665699/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Dec 3:S0735-1097(24)10429-9. doi: 10.1016/j.jacc.2024.10.112. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39665699/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39665699</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.10.112>10.1016/j.jacc.2024.10.112</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39665699</guid>
<pubDate>Thu, 12 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Patrick T O'Gara</dc:creator>
<dc:date>2024-12-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Transcatheter Aortic Valve Replacement in Heart Failure, Reduced Ejection Fraction, and Moderate Aortic Stenosis</dc:title>
<dc:identifier>pmid:39665699</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.10.112</dc:identifier>
</item>
<item>
<title>Obesity-Related Heart Failure With Preserved Ejection Fraction: Weighing the Benefit of Finerenone</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39665698/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Dec 6:S0735-1097(24)10542-6. doi: 10.1016/j.jacc.2024.11.033. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39665698/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39665698</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.11.033>10.1016/j.jacc.2024.11.033</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39665698</guid>
<pubDate>Thu, 12 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Amanda R Vest</dc:creator>
<dc:creator>Andrew J Sauer</dc:creator>
<dc:date>2024-12-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Obesity-Related Heart Failure With Preserved Ejection Fraction: Weighing the Benefit of Finerenone</dc:title>
<dc:identifier>pmid:39665698</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.11.033</dc:identifier>
</item>
<item>
<title>In CASTLE-HTx Trial We Trust</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39665697/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Nov 27:S0735-1097(24)10285-9. doi: 10.1016/j.jacc.2024.10.092. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39665697/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39665697</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.10.092>10.1016/j.jacc.2024.10.092</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39665697</guid>
<pubDate>Thu, 12 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Christian Sohns</dc:creator>
<dc:creator>Nassir F Marrouche</dc:creator>
<dc:creator>Harry J G M Crijns</dc:creator>
<dc:creator>Samuel Sossalla</dc:creator>
<dc:creator>Vanessa Sciacca</dc:creator>
<dc:creator>Jan G P Tijssen</dc:creator>
<dc:creator>Philipp Sommer</dc:creator>
<dc:creator>CASTLE-HTx Investigators</dc:creator>
<dc:date>2024-12-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>In CASTLE-HTx Trial We Trust</dc:title>
<dc:identifier>pmid:39665697</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.10.092</dc:identifier>
</item>
<item>
<title>Incidental and Progressive Tobacco Smoking in Childhood and Subsequent Risk of Premature Cardiac Damage</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39665696/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Nov 23:S0735-1097(24)09964-9. doi: 10.1016/j.jacc.2024.09.1229. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39665696/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39665696</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.09.1229>10.1016/j.jacc.2024.09.1229</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39665696</guid>
<pubDate>Thu, 12 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Andrew O Agbaje</dc:creator>
<dc:date>2024-12-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Incidental and Progressive Tobacco Smoking in Childhood and Subsequent Risk of Premature Cardiac Damage</dc:title>
<dc:identifier>pmid:39665696</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.09.1229</dc:identifier>
</item>
<item>
<title>Giving Cardiovascular Clinicians a Voice in Evidence Generation: A Collaboration Between FDA and JACC</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39665695/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Dec 10:S0735-1097(24)10509-8. doi: 10.1016/j.jacc.2024.11.022. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39665695/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39665695</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.11.022>10.1016/j.jacc.2024.11.022</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39665695</guid>
<pubDate>Thu, 12 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Haider J Warraich</dc:creator>
<dc:creator>Harlan M Krumholz</dc:creator>
<dc:creator>Robert M Califf</dc:creator>
<dc:date>2024-12-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Giving Cardiovascular Clinicians a Voice in Evidence Generation: A Collaboration Between FDA and JACC</dc:title>
<dc:identifier>pmid:39665695</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.11.022</dc:identifier>
</item>
<item>
<title>In focus: Bernhard Gerber takes on editorship of Cardiovascular Imaging</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39665270/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 12:ehae852. doi: 10.1093/eurheartj/ehae852. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39665270/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39665270</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae852>10.1093/eurheartj/ehae852</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39665270</guid>
<pubDate>Thu, 12 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Judith Ozkan</dc:creator>
<dc:date>2024-12-12</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>In focus: Bernhard Gerber takes on editorship of Cardiovascular Imaging</dc:title>
<dc:identifier>pmid:39665270</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae852</dc:identifier>
</item>
<item>
<title>Shaping the future of cardiovascular research: a focus on cardioimmunology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39663739/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 12:ehae783. doi: 10.1093/eurheartj/ehae783. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39663739/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39663739</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae783>10.1093/eurheartj/ehae783</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39663739</guid>
<pubDate>Thu, 12 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Soumaya Ben-Aicha</dc:creator>
<dc:creator>Emiel P C van der Vorst</dc:creator>
<dc:date>2024-12-12</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Shaping the future of cardiovascular research: a focus on cardioimmunology</dc:title>
<dc:identifier>pmid:39663739</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae783</dc:identifier>
</item>
<item>
<title>Left atrial appendage closure after ablation: the best OPTION for patients with AF?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39663367/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Dec 11. doi: 10.1038/s41569-024-01113-y. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39663367/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39663367</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01113-y>10.1038/s41569-024-01113-y</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39663367</guid>
<pubDate>Wed, 11 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Karina Huynh</dc:creator>
<dc:date>2024-12-11</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Left atrial appendage closure after ablation: the best OPTION for patients with AF?</dc:title>
<dc:identifier>pmid:39663367</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01113-y</dc:identifier>
</item>
<item>
<title>Reply: Considerations on the SI! Program for Elementary Schools Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39663012/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Dec 17;84(25):e357-e358. doi: 10.1016/j.jacc.2024.09.1241.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39663012/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39663012</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.09.1241>10.1016/j.jacc.2024.09.1241</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39663012</guid>
<pubDate>Wed, 11 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Gloria Santos-Beneit</dc:creator>
<dc:creator>Rodrigo Fernández-Jiménez</dc:creator>
<dc:creator>Valentin Fuster</dc:creator>
<dc:creator>SI! Program for Elementary Schools Trial Investigators</dc:creator>
<dc:date>2024-12-11</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Reply: Considerations on the SI! Program for Elementary Schools Trial</dc:title>
<dc:identifier>pmid:39663012</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.09.1241</dc:identifier>
</item>
<item>
<title>Effect of Time-Varying Exposure to School-Based Health Promotion on Adiposity in Childhood</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39663011/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Dec 17;84(25):e355. doi: 10.1016/j.jacc.2024.08.084.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39663011/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39663011</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.08.084>10.1016/j.jacc.2024.08.084</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39663011</guid>
<pubDate>Wed, 11 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Ying Fang</dc:creator>
<dc:creator>Changlin Zhai</dc:creator>
<dc:creator>Haihua Pan</dc:creator>
<dc:date>2024-12-11</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Effect of Time-Varying Exposure to School-Based Health Promotion on Adiposity in Childhood</dc:title>
<dc:identifier>pmid:39663011</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.08.084</dc:identifier>
</item>
<item>
<title>Refining Health Interventions: Addressing Developmental Differences and Focusing on Creative Thinking in Children</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39663010/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Dec 17;84(25):e353-e354. doi: 10.1016/j.jacc.2024.08.086.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39663010/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39663010</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.08.086>10.1016/j.jacc.2024.08.086</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39663010</guid>
<pubDate>Wed, 11 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Hanjun Ma</dc:creator>
<dc:creator>Jiangmi Mo</dc:creator>
<dc:creator>Zonglong He</dc:creator>
<dc:creator>Qunqiang Luo</dc:creator>
<dc:date>2024-12-11</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Refining Health Interventions: Addressing Developmental Differences and Focusing on Creative Thinking in Children</dc:title>
<dc:identifier>pmid:39663010</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.08.086</dc:identifier>
</item>
<item>
<title>REPLY: Generalizability of the Mass General Brigham Lp(a) Registry Study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39663009/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Dec 17;84(25):e351-e352. doi: 10.1016/j.jacc.2024.09.1239.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39663009/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39663009</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.09.1239>10.1016/j.jacc.2024.09.1239</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39663009</guid>
<pubDate>Wed, 11 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Adam N Berman</dc:creator>
<dc:creator>David W Biery</dc:creator>
<dc:creator>Brittany N Weber</dc:creator>
<dc:creator>Deepak L Bhatt</dc:creator>
<dc:creator>None Ron Blankstein</dc:creator>
<dc:date>2024-12-11</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>REPLY: Generalizability of the Mass General Brigham Lp(a) Registry Study</dc:title>
<dc:identifier>pmid:39663009</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.09.1239</dc:identifier>
</item>
<item>
<title>Generalizability of the Mass General Brigham Lp(a) Registry Study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39663008/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Dec 17;84(25):e349. doi: 10.1016/j.jacc.2024.08.085.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39663008/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39663008</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.08.085>10.1016/j.jacc.2024.08.085</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39663008</guid>
<pubDate>Wed, 11 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Kazuo Komamura</dc:creator>
<dc:creator>Hiroshi Miyake</dc:creator>
<dc:creator>Koichi Kobayashi</dc:creator>
<dc:creator>Mitsunori Iwase</dc:creator>
<dc:date>2024-12-11</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Generalizability of the Mass General Brigham Lp(a) Registry Study</dc:title>
<dc:identifier>pmid:39663008</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.08.085</dc:identifier>
</item>
<item>
<title>Acute Respiratory Infections Fuel Cardiovascular Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39663007/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Dec 17;84(25):2468-2470. doi: 10.1016/j.jacc.2024.10.079.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39663007/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39663007</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.10.079>10.1016/j.jacc.2024.10.079</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39663007</guid>
<pubDate>Wed, 11 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Florien S van Royen</dc:creator>
<dc:creator>Roderick P Venekamp</dc:creator>
<dc:creator>Patricia C J L Bruijning-Verhagen</dc:creator>
<dc:creator>Frans H Rutten</dc:creator>
<dc:date>2024-12-11</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Acute Respiratory Infections Fuel Cardiovascular Disease</dc:title>
<dc:identifier>pmid:39663007</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.10.079</dc:identifier>
</item>
<item>
<title>Improving Outcome in Patients With Tricuspid Regurgitation: Look At the Kidneys and the Liver!</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39663006/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Dec 17;84(25):2457-2459. doi: 10.1016/j.jacc.2024.09.1238.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39663006/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39663006</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.09.1238>10.1016/j.jacc.2024.09.1238</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39663006</guid>
<pubDate>Wed, 11 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Marco Metra</dc:creator>
<dc:creator>Marianna Adamo</dc:creator>
<dc:creator>Javed Butler</dc:creator>
<dc:date>2024-12-11</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Improving Outcome in Patients With Tricuspid Regurgitation: Look At the Kidneys and the Liver!</dc:title>
<dc:identifier>pmid:39663006</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.09.1238</dc:identifier>
</item>
<item>
<title>Mediterranean diet, neutrophil count, and carotid intima-media thickness in secondary prevention: the CORDIOPREV study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39661486/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241212195718&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: These findings suggest that neutrophils may represent a promising target for preventing atherosclerosis. A Mediterranean diet could serve as an effective dietary strategy to reduce neutrophil levels and potentially slow the progression of atherosclerosis, offering a new neutrophil-reducing therapy concept. Further research is essential to gain deeper insights into the role of neutrophils in the pathophysiology of atherosclerotic cardiovascular disease in humans.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 11:ehae836. doi: 10.1093/eurheartj/ehae836. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Several studies have supported the role of innate immune system as a key factor in the sterile inflammation underlying the pathophysiology of atherosclerosis in mice. However, its involvement in humans remains unclear. This study aimed to explore the association between neutrophil count, and the intima-media thickness of common carotid arteries (IMT-CC), as well as the potential impact of long-term dietary interventions on these associations.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A comprehensive analysis was conducted within the framework of the CORDIOPREV study, a long-term secondary prevention study involving dietary interventions with either a Mediterranean or a low-fat diet. The study evaluated the relationship between absolute neutrophil count and neutrophil-related ratios with IMT-CC at baseline and after 5 and 7 years of dietary intervention.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: At baseline, patients in the highest tertile of neutrophil count had a higher IMT-CC and number of carotid plaques, when compared to lowest tertile (P &lt; .01 and P &lt; .05, respectively). Logistic regression analyses supported this association. Elevated neutrophil count, neutrophil-to-erythrocyte ratio, and neutrophil-to-HDL ratio were associated with an increased likelihood of having an IMT-CC >;.9 mm {odds ratio (OR) 1.17 [95% confidence interval (CI) 1.04-1.35], OR 2.21 (95% CI 1.24-4.12), and OR 1.96 (95% CI 1.09-3.55), respectively}, after adjustment for all variables, which was corroborated by linear regression. Furthermore, a linear mixed-effect model analysis from a longitudinal analysis spanning 5 and 7 years revealed an increase in 1 unit of neutrophils/μl at these time points was associated with a mean increase of .004 (.002) mm in the IMT-CC (P = .031) after adjustment for all variables. Interestingly, in patients exhibiting regression in IMT-CC after 7 years of follow-up, those following a Mediterranean diet showed a significant decrease in neutrophil count after 5 and 7 years (both with P &lt; .05), compared to baseline.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: These findings suggest that neutrophils may represent a promising target for preventing atherosclerosis. A Mediterranean diet could serve as an effective dietary strategy to reduce neutrophil levels and potentially slow the progression of atherosclerosis, offering a new neutrophil-reducing therapy concept. Further research is essential to gain deeper insights into the role of neutrophils in the pathophysiology of atherosclerotic cardiovascular disease in humans.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39661486/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241212195718&v=2.18.0.post9+e462414">39661486</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae836>10.1093/eurheartj/ehae836</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39661486</guid>
<pubDate>Wed, 11 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Hatim Boughanem</dc:creator>
<dc:creator>José D Torres-Peña</dc:creator>
<dc:creator>Antonio Pablo Arenas-de Larriva</dc:creator>
<dc:creator>Juan L Romero-Cabrera</dc:creator>
<dc:creator>Purificación Gómez-Luna</dc:creator>
<dc:creator>Laura Martín-Piedra</dc:creator>
<dc:creator>Fernando Rodríguez-Cantalejo</dc:creator>
<dc:creator>Francisco J Tinahones</dc:creator>
<dc:creator>Elena M Yubero Serrano</dc:creator>
<dc:creator>Oliver Soehnlein</dc:creator>
<dc:creator>Pablo Perez-Martinez</dc:creator>
<dc:creator>Javier Delgado-Lista</dc:creator>
<dc:creator>José López-Miranda</dc:creator>
<dc:date>2024-12-11</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Mediterranean diet, neutrophil count, and carotid intima-media thickness in secondary prevention: the CORDIOPREV study</dc:title>
<dc:identifier>pmid:39661486</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae836</dc:identifier>
</item>





























</channel>
</rss>